Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -15 | -35 | -11 | -6 | 1 |
| Other Working Capital | -638 | -473 | 169 | 819 | 147 |
| Other Operating Activity | -1,157 | -1,661 | -1,688 | -2,085 | -1,695 |
| Operating Cash Flow | $-1,809 | $-2,169 | $-1,530 | $-1,271 | $-1,548 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,750 | 104 | 1,210 | 189 | 290 |
| Other Financing Activity | -225 | 2,157 | -56 | 0 | 0 |
| Financing Cash Flow | $4,525 | $2,262 | $1,154 | $189 | $290 |
| Beginning Cash Position | 162 | 131 | 507 | 1,589 | 2,847 |
| End Cash Position | 2,878 | 162 | 131 | 507 | 1,589 |
| Net Cash Flow | $2,715 | $32 | $-376 | $-1,082 | $-1,258 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,809 | -2,169 | -1,530 | -1,271 | -1,548 |
| Free Cash Flow | -1,809 | -2,169 | -1,530 | -1,271 | -1,548 |